Through
2/14
Researchers within the Penn Pancreatic Research Center and beyond continue to seek innovative ways to treat and detect this deadly disease—and are making promising progress.
Penn researchers show how the FDA-approved drug liraglutide interacts with a distinct set of neurons in the brain’s “energy balance” system to suppress appetite.
A Penn study shows a better clinical response to immunotherapy correlates with higher ratio of tumor mutations detected by a liquid biopsy.
Meet Vikram Paralkar, an oncologist at Penn Medicine who has received extraordinary attention for his new fiction novel, “Night Theater,” a story where a surgeon is asked to bring the dead back to life.
Medical professionals from the Perelman School of Medicine, the School of Dental Medicine, and the School of Veterinary Medicine discuss treating pain during the opioid crisis.
The novel disease is serious. But risks here remain low, says Ezekiel J. Emanuel, vice provost for global initiatives, who attended a World Health Organization meeting on the subject last week.
The insights from the PEXIVAS Trial, a 10-year study, shows treatment for ANCA-associated vasculitis can become much more patient-friendly and reduces kidney failure, for which vasculitis patients are often at risk.
A first-of-its-kind analysis provides the latest evidence showing how addressing unmet social needs can improve health and cut costs.
With a protein drug grown in the leaves of lettuce plants, the School of Dental Medicine’s Henry Daniell and colleagues hope to provide new treatment options for patients with pulmonary arterial hypertension, a rare but deadly disease.
A new study from Penn Medicine finds Black patients are less likely than white peers to receive systemic treatments and acne medication overall.
Meredith Mann
meredith.mann@pennmedicine.upenn.edu
A study led by Victor Roy of the Perelman School of Medicine finds that consumers and employers ultimately contributed to corporate health profits by paying for insurance premiums, out-of-pocket medical bills, and taxes.
FULL STORY →
Robert Schwab of the Perelman School of Medicine says that, if statins worked perfectly, cardiovascular disease wouldn’t remain the leading cause of death worldwide.
FULL STORY →
Xiaowei (George) Xu of the Perelman School of Medicine and colleagues have unveiled an innovative approach to cancer treatment that leverages tiny capsules known as small extracellular vesicles to target a specific receptor on tumor cells.
FULL STORY →
Drew Weissman and Scott Hensley of the Perelman School of Medicine are testing a vaccine to prevent a strain of H5N1 bird flu in chickens and cattle.
FULL STORY →
Colleen Tewksbury of the School of Nursing and Perelman School of Medicine says that the vast majority of people in the U.S. already get enough protein from the foods they eat and don’t need to take it in supplement form.
FULL STORY →
Samir Mehta of the Perelman School of Medicine says that older adults playing sports need to understand who their competition is and make sure they’re playing with people who are at the appropriate level.
FULL STORY →